TTrialPathMatch Me to Trials
← Back to trials
RecruitingCoronary Artery DiseaseCoronary Artery Disease Risk HighComplex Coronary Artery Disease

IVUS CHIP UPP Registry

Eligible age

18+ yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.

Sponsor: ECRI bv

You may qualify if…

  • ✓ 1. The patient must be ≥18 years of age and self-identify within a US census-defined minority
  • ✓ 2. Patients with an indication for PCI of at least one lesion satisfying any of the following criteria:
  • ✓ 1. Angiographic heavy calcification
  • ✓ 2. Ostial lesions
  • ✓ 3. True bifurcation lesions involving side-branches \>2.5mm
  • ✓ 4. Left main lesions
  • ✓ 5. Chronic total occlusion
  • ✓ 6. In-stent restenosis

You may not qualify if…

  • ✕ 1. ST-elevation myocardial infarction or cardiogenic shock within prior 7 days
  • ✕ 2. Known untreated severe valvular heart disease
  • ✕ 3. Contraindication on the use of IVUS (i.e. extreme vessel tortuosity)
  • ✕ 4. Requiring PCI in a diseased aorto-coronary bypass
  • ✕ 5. Known contraindication or hypersensitivity to anticoagulants
  • ✕ 6. Absolute contraindications or allergy that cannot be pre-medicated, to iodinated contrast or to antiplatelet drugs, including both aspirin and P2Y12 inhibitors
  • ✕ 7. Non-cardiac co-morbidities with a life expectancy less than 1 year
  • ✕ 8. A patients that is currently participating in a clinical trial that has not yet reached its primary endpoint cannot be included in this registry. A patient may only be enrolled in this registry once.

Where it's recruiting

Arizona

Phoenix

California

Loma Linda

Florida

Coral Gables · Orlando · Tampa · Weston

Georgia

Atlanta

Illinois

Chicago

Kentucky

Louisville

Michigan

Detroit

Minnesota

Duluth

New Jersey

Jersey City · Marlton

Rhode Island

Providence

Source: ClinicalTrials.gov · NCT06625801 · last updated 2026-09-23